Cairo – Mubasher: The net profits of Nile Co. for Pharmaceuticals and Chemical Industries (Nile Pharma) declined by 3.9% year-on-year (YoY) to EGP 34.2 million in the first four months of the current fiscal year, compared to EGP 35.6 million.
During the first quarter (Q1) of 2021, the company's net profits retreated by 16% to EGP 18.71 million from EGP 22.29 million in the year-ago period.
The revenues retreated to EGP 207.3 million in the July-September period, compared to EGP 218.42 million in the same period a year earlier.
